Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Corrigendum: The loss of ATP2C1 impairs the DNA damage response and induces altered skin homeostasis: Consequences for epidermal biology in Hailey-Hailey disease.

Cialfi S, Le Pera L, De Blasio C, Mariano G, Palermo R, Zonfrilli A, Uccelletti D, Palleschi C, Biolcati G, Barbieri L, Screpanti I, Talora C.

Sci Rep. 2017 Mar 16;7:44514. doi: 10.1038/srep44514. No abstract available.

2.

Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.

Barman-Aksoezen J, Girelli D, Aurizi C, Schneider-Yin X, Campostrini N, Barbieri L, Minder EI, Biolcati G.

J Inherit Metab Dis. 2017 May;40(3):433-441. doi: 10.1007/s10545-017-0017-7. Epub 2017 Feb 9.

PMID:
28185024
3.

The loss of ATP2C1 impairs the DNA damage response and induces altered skin homeostasis: Consequences for epidermal biology in Hailey-Hailey disease.

Cialfi S, Le Pera L, De Blasio C, Mariano G, Palermo R, Zonfrilli A, Uccelletti D, Palleschi C, Biolcati G, Barbieri L, Screpanti I, Talora C.

Sci Rep. 2016 Aug 16;6:31567. doi: 10.1038/srep31567. Erratum in: Sci Rep. 2017 Mar 16;7:44514.

4.

Glutathione S-transferase ϴ-subunit as a phenotypic suppressor of pmr1Δ strain, the Kluyveromyces lactis model for Hailey-Hailey disease.

Ficociello G, Zanni E, Cialfi S, Aurizi C, Biolcati G, Palleschi C, Talora C, Uccelletti D.

Biochim Biophys Acta. 2016 Nov;1863(11):2650-2657. doi: 10.1016/j.bbamcr.2016.08.002. Epub 2016 Aug 11.

5.

Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes.

Radio FC, Majore S, Aurizi C, Sorge F, Biolcati G, Bernabini S, Giotti I, Torricelli F, Giannarelli D, De Bernardo C, Grammatico P.

Blood Cells Mol Dis. 2015 Jun;55(1):71-5. doi: 10.1016/j.bcmd.2015.04.001. Epub 2015 Apr 16.

PMID:
25976471
6.

Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.

Nemethova M, Radvanszky J, Kadasi L, Ascher DB, Pires DE, Blundell TL, Porfirio B, Mannoni A, Santucci A, Milucci L, Sestini S, Biolcati G, Sorge F, Aurizi C, Aquaron R, Alsbou M, Lourenço CM, Ramadevi K, Ranganath LR, Gallagher JA, van Kan C, Hall AK, Olsson B, Sireau N, Ayoob H, Timmis OG, Sang KH, Genovese F, Imrich R, Rovensky J, Srinivasaraghavan R, Bharadwaj SK, Spiegel R, Zatkova A.

Eur J Hum Genet. 2016 Jan;24(1):66-72. doi: 10.1038/ejhg.2015.60. Epub 2015 Mar 25.

7.

Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria.

Biolcati G, Marchesini E, Sorge F, Barbieri L, Schneider-Yin X, Minder EI.

Br J Dermatol. 2015 Jun;172(6):1601-1612. doi: 10.1111/bjd.13598. Epub 2015 Apr 30.

PMID:
25494545
8.

Erythropoietic protoporphyria in a boy.

Buonuomo PS, Macchiaiolo M, Gonfiantini MV, Biolcati G, Pitisci A, Villani A, Bartuli A.

Arch Dis Child. 2015 Jan;100(1):7. doi: 10.1136/archdischild-2014-307082. Epub 2014 Nov 12. No abstract available.

PMID:
25392202
9.

In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.

Barman-Aksözen J, Minder EI, Schubiger C, Biolcati G, Schneider-Yin X.

Blood Cells Mol Dis. 2015 Jan;54(1):71-7. doi: 10.1016/j.bcmd.2014.07.017. Epub 2014 Aug 30.

PMID:
25179834
10.

A challenging diagnosis for potential fatal diseases: recommendations for diagnosing acute porphyrias.

Ventura P, Cappellini MD, Biolcati G, Guida CC, Rocchi E; Gruppo Italiano Porfiria (GrIP).

Eur J Intern Med. 2014 Jul;25(6):497-505. doi: 10.1016/j.ejim.2014.03.011. Epub 2014 May 5. Review.

PMID:
24809927
11.

Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte-stimulating hormone in the treatment of patients with Hailey-Hailey disease.

Biolcati G, Aurizi C, Barbieri L, Cialfi S, Screpanti I, Talora C.

Clin Exp Dermatol. 2014 Mar;39(2):168-75. doi: 10.1111/ced.12203. Epub 2013 Oct 25.

12.

Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation.

Manca S, Magrelli A, Cialfi S, Lefort K, Ambra R, Alimandi M, Biolcati G, Uccelletti D, Palleschi C, Screpanti I, Candi E, Melino G, Salvatore M, Taruscio D, Talora C.

Exp Dermatol. 2011 Nov;20(11):932-7. doi: 10.1111/j.1600-0625.2011.01359.x. Epub 2011 Sep 14.

PMID:
21913998
13.

Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease.

Cialfi S, Oliviero C, Ceccarelli S, Marchese C, Barbieri L, Biolcati G, Uccelletti D, Palleschi C, Barboni L, De Bernardo C, Grammatico P, Magrelli A, Salvatore M, Taruscio D, Frati L, Gulino A, Screpanti I, Talora C.

Br J Dermatol. 2010 Mar;162(3):518-26. doi: 10.1111/j.1365-2133.2009.09500.x. Epub 2009 Nov 9.

PMID:
19903178
14.

CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.

D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):155-64.

PMID:
19828092
15.

Association between porphyria cutanea tarda and beta-thalassemia major.

Barbieri L, Macrì A, Lupia Palmieri G, Aurizi C, Biolcati G.

Cell Mol Biol (Noisy-le-grand). 2009 Jul 1;55(2):36-9.

PMID:
19656449
16.

Four novel mutations of the coproporphyrinogen III oxidase gene.

Aurizi C, Lupia Palmieri G, Barbieri L, Macrì A, Sorge F, Usai G, Biolcati G.

Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):15-8.

PMID:
19267996
17.

Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.

Aurizi C, Schneider-Yin X, Sorge F, Macrì A, Minder EI, Biolcati G.

Mol Genet Metab. 2007 Apr;90(4):402-7. Epub 2006 Dec 29.

PMID:
17196862
18.

1599: first iconographic description of hepatoerythropoietic porphyria.

Biolcati G, Dolazza C.

Int J Dermatol. 2006 Aug;45(8):976-8.

PMID:
16911388
19.

ATP2C1 gene mutation analysis in Italian patients with Hailey-Hailey disease.

Majore S, Biolcati G, Barboni L, Cannistraci C, Binni F, Crisi A, Picardo M, Grammatico P.

J Invest Dermatol. 2005 Nov;125(5):933-5.

20.

Dermatological marks in athletes of artistic and rhythmic gymnastics.

Biolcati G, Berlutti G, Bagarone A, Caselli G.

Int J Sports Med. 2004 Nov;25(8):638-40.

PMID:
15532010
21.

A case of variegate porphyria with coeliac disease and beta-thalassaemia minor.

Dal Sacco D, Parodi A, Cozzani E, Biolcati G, Griso D, Rebora A.

Dermatology. 2004;209(2):161-2. No abstract available.

PMID:
15316176
22.

Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.

Martinez di Montemuros F, Di Pierro E, Patti E, Tavazzi D, Danielli MG, Biolcati G, Rocchi E, Cappellini MD.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.

PMID:
12699245
23.

Genetic analysis of variegate porphyria (VP) in Italy: identification of six novel mutations in the protoporphyrinogen oxidase (PPOX) gene.

D'Amato M, Bonuglia M, Barile S, Griso D, Macri A, Biolcati G.

Hum Mutat. 2003 Apr;21(4):448.

PMID:
12655566
24.

Acute intermittent porphyria: heterogeneity of mutations in the hydroxymethylbilane synthase gene in Italy.

Martinez di Montemuros F, Di Pierro E, Biolcati G, Rocchi E, Bissolotti E, Tavazzi D, Fiorelli G, Cappellini MD.

Blood Cells Mol Dis. 2001 Nov-Dec;27(6):961-70.

PMID:
11831862
25.

Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria.

Grieco A, Alfei B, Di Rocco P, Miele L, Biolcati G, Griso D, Vecchio FM, Bianco A, Gasbarrini G.

Eur J Gastroenterol Hepatol. 2001 Aug;13(8):973-5.

PMID:
11507366
26.

[Skeletal radiologic aspects of 2 rare cases of porphyria].

Solivetti FM, Biolcati G, Macrì A, Griso D.

Radiol Med. 2000 Jan-Feb;99(1-2):91-3. Italian. No abstract available.

PMID:
10803195
27.

Molecular analysis of the hydroxymethylbilane synthase (HMBS) gene in Italian patients with acute intermittent porphyria: report of four novel mutations.

Martinez di Montemuros F, Di Pierro E, Fargion S, Biolcati G, Griso D, Macrì A, Fiorelli G, Cappellini MD.

Hum Mutat. 2000 May;15(5):480.

PMID:
10790212
28.

Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy.

D'Amato M, Macrí A, Griso D, Biolcati G, Ameglio F.

J Invest Dermatol. 1998 Dec;111(6):1241-2. No abstract available.

29.

Creeping eruption of larva migrans--a case report in a beach volley athlete.

Biolcati G, Alabiso A.

Int J Sports Med. 1997 Nov;18(8):612-3.

PMID:
9443594
30.

Iron and porphyria cutanea tarda.

D'Alessandro Gandolfo L, Griso D, Macrì A, Biolcati G, Barlattani A, Topi GC.

Cell Mol Biol (Noisy-le-grand). 1997 Feb;43(1):75-9.

PMID:
9074791
31.

Eruptive syringoma.

Biolcati G, Donati P.

J Am Acad Dermatol. 1993 May;28(5 Pt 1):800-1. No abstract available.

PMID:
8496437
32.

Incidence of hereditary porphyria cutanea tarda (PCT) in a sample of the Italian population.

D'Alessandro L, Griso D, Biolcati G, Macrì A, Topi GC.

Arch Dermatol Res. 1992;284(4):212-4.

PMID:
1358034
33.

Homozygous variegate porphyria: revision of a diagnostic error.

D'Alessandro Gandolfo L, Macri A, Biolcati G, Griso D, Phung LN, Deybach JC, Da Silva V, Nordmann Y, Topi GC.

Br J Dermatol. 1991 Feb;124(2):211. No abstract available.

PMID:
2004012
34.

[An unusual mechanism of lead poisoning. Presentation of a case].

D'Alessandro Gandolfo L, Macrì A, Biolcati G, Rossi F, Cirelli A, Barlattani A, Topi GC.

Recenti Prog Med. 1989 Mar;80(3):140-1. Italian.

PMID:
2740602
35.

Does an association exist between PCT and SLE? Results of a study on autoantibodies in 158 patients affected with PCT.

Griso D, Macrì A, Biolcati G, Topi G.

Arch Dermatol Res. 1989;281(4):291-2. No abstract available.

PMID:
2774662
36.

Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?

D'Alessandro Gandolfo L, Griso D, Macri A, Biolcati G, Topi GC.

Dermatologica. 1989;178(4):206-8.

PMID:
2767288
37.

Segmental abdominal zoster paresis.

Jandolo B, Biolcati G, Montanari U, Pietrangeli A, Fazio M.

Riv Neurol. 1987 Jul-Aug;57(4):274-6.

PMID:
2961042
38.

[Morphofunctional evaluation of hepatic injury in porphyria cutaneous tarda by isotopic diagnosis with radiocolloids and bilio-tropic tracers].

Biolcati GF, D'Alessandro Gandolfo L, Griso D, Macrì A, Menghini ML, Pigorini F, Topi GC.

Minerva Dietol Gastroenterol. 1987 Jan-Mar;33(1):33-8. Italian. No abstract available.

PMID:
3587691

Supplemental Content

Loading ...
Support Center